Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Retinavitreous Associate Ltd

Neither a doctor nor a teaching hospital

Research payments

$679,796

72 payments

Through program year 2025, Retinavitreous Associate Ltd is reported as receiving $679,796 in research payments, across 72 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $211,048 15
2024 Research $137,190 14
2023 Research $310,831 41
2022 Research $20,726 2

Breakdown

Who paid Research payments · program years 2022–2025
  1. Genentech, Inc. $679,796 72 payments
Studies the money was for Research payments · program years 2022–2025
  1. Phase IIa Geographic Atrophy Study $240,830 14 payments
  2. Phase 2 of Ro7171009 in Ga $231,127 26 payments
  3. Faricimab for Under Represented Patients With Dme $118,473 18 payments
  4. PH 2 Open Label Extension of Ahtra1 in Ga $51,491 13 payments
  5. A Phase 1 Sad MD in Diabetic MacUlar Edema $37,874 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record